19.05.2011 • NewsGen-ProbeThermo FisherNovartis

Bidders Emerge For Gen-Probe, Phadia

Bidders emerged for allergy-testing company Phadia and diagnostic test-maker Gen-Probe, according to The Wall Street Journal.

Laboratory equipment company Thermo Fisher Scientific is a leading contender for privately owned Phadia, and is involved in the auction for Gen-Probe, the newspaper reported in its online edition.

Phadia could fetch as much as $3 billion in a sale, while Gen-Probe has a market capitalization of $3.8 billion.

Other bidders for Gen-Probe include Novartis, and Life Technologies Corp, the newspaper said.

Gen-Probe, Phadia, Thermo Fisher declined to comment. Life Technologies and Novartis, which has a partnership with Gen-Probe, could not be immediately reached for comment.

Last month, Gen-Probe hired Morgan Stanley to seek a buyer for the company, sources familiar with the situation said.

 

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.